Barclays’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-400
Closed -$42K 7004
2018
Q1
$42K Buy
+400
New +$46.5K ﹤0.01% 6013
2014
Q4
Sell
-2,200
Closed -$169K 7309
2014
Q3
$169K Buy
+2,200
New +$170K ﹤0.01% 4893
2013
Q3
Sell
-50,000
Closed -$3.7M 7434
2013
Q2
$3.7M Buy
+50,000
New +$3.35M ﹤0.01% 1885

Other funds holding CRI

Barclays's CRI Position: Q1 2026 in Review

Barclays reduced its Carter's (CRI) stake by 51% in Q1 2026, selling an estimated $1.11M and leaving 29,555 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2725.

Barclays first reported a position in CRI in Q2 2013 and has held it in 52 quarters since. The position peaked at $28.5M in Q1 2019. 275 funds tracked by Wall St. Rank hold CRI as of Q1 2026.

  • Barclays held 29,555 shares of Carter's worth $1.06M as of Q1 2026.
  • Barclays sold 30,538 Carter's shares in Q1 2026, an estimated $1.11M.
  • Carter's made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2725 holding.
  • Barclays first reported a position in Carter's in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Carter's position peaked at $28.5M in Q1 2019.
  • 275 funds tracked by Wall St. Rank held Carter's as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.